ORAMED PHARMACEUTICALS INC.: cash_and_equivalents
| Value | {"amount": 3295000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-02-28) |
| Status | current |
| Entity | ORAMED PHARMACEUTICALS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:50:43.271624+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0343e6f2-bebc-46f8-97d9-d4ac5deb1a50
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-18-004196Retrieved: 2026-08-19T11:50:43.271624+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001176309/cash-and-equivalents/2018-02-28 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0343e6f2-bebc-46f8-97d9-d4ac5deb1a50
History
- no predecessors — first report